- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Demand for nanotechnology medical products will increase over 17 percent per
year to $53 billion in 2011. Afterwards, the increasing flow of new nanomedicines,
nanodiagnostics, and nanotech-based medical supplies and devices into the US
marketplace will boost demand to more than $110 billion in 2016. These and other
trends are presented in Nanotechnology in Healthcare, a new study from The
Freedonia Group, Inc., a Cleveland-based industry research firm.
The critical need for new or improved therapies for many medical conditions will
promote the adaptation of nanotechnology to an expanding number of
pharmaceuticals. The total market for nanomedicines will command strong growth
over the long term. Treatments based on humanized monoclonal antibodies,
nanopolymers and nanoproteins will drive gains, with compounds for cancer, heart
diseases, neurological disorders and viral infections leading new product introductions
and growth opportunities.
Advances in nanotechnology will also contribute significant improvements to the
quality and performance of medical diagnostic products. Nanosized monoclonal
antibody labels and DNA probes will greatly enhance the speed, accuracy, capabilities
and cost-effectiveness of in vitro diagnostic testing, drug discovery and medical
research procedures. Nanoparticle formulations of superparamagnetic iron oxide,
gadolinium, perfluorocarbon and specialty polymers will broaden in vivo imaging
capabilities. Several medical supplies and devices will emerge as key applications
for nanotechnology. Nanomaterials are already gaining significant demand as active
ingredients of burn dressings, bone cement, bone substitutes, and dental repair and
The greatest short-term impact of nanotechnology in health care will be in
therapies and diagnostics for cancer and central nervous system disorders.
Gradually, many other major diseases, as well as injuries, will be treated and detected
routinely by nanotechnology products. By 2016, nanoimplants will be widely employed
in orthopedic procedures and begin to gain experimental uses in tissue and neuron
regeneration. By 2021, nanotechnology will serve applications that extend into most
areas of critical and chronic care. Additionally, the development of monoclonal antibody and nanomaterial vaccines and, to a lesser extent, controlled-release nutritional preparations will create a large preventive medicine market.
About Nanotechnology in Healthcare
Nanotechnology in Healthcare (published 02/2007, 349 pages) is available for $4,500 from The Freedonia Group, Inc., 767 Beta Drive, Cleveland, OH 44143-2326. For further details, please contact Corinne Gangloff by phone 440.684.9600, fax 440.646.0484 or e-mail
A limited license to use or reprint information from this news release is granted to you provided attribution for the same – including, if possible, the price of the report – is given to The Freedonia Group, Inc. (Cleveland, OH). We would also appreciate the courtesy of receiving a copy of the article or publication in which we appear.
For more information, please click here
Copyright © The Freedonia Group, IncIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Call for NanoArt and Art-Science-Technology Papers June 9th, 2016
Are humans the new supercomputer?Today, people of all backgrounds can contribute to solving serious scientific problems by playing computer games. A Danish research group has extended the limits of quantum physics calculations and simultaneously blurred the boundaries between mac April 14th, 2016